The increases in bone mineral density of about 1.65 per cent observed in men after receiving vitamin D and calcium supplements were still evident 18 months after the men stopped taking the supplements, researchers report in this month's American Journal of Clinical Nutrition.The increases in bone mineral density of about 1.65 per cent observed in men after receiving vitamin D and calcium supplements were still evident 18 months after the men stopped taking the supplements, researchers report in this month's American Journal of Clinical Nutrition.
The study shows that elderly men, a population that is often overlooked in bone health studies, could also benefit from daily supplements of fortified milk.
Much focus has been on the vitamin D and calcium combination for bone health in women since elderly females are four times as likely to develop osteoporosisthan their male counterparts. The new study, which follows on from an earlier study in the journal Bone (doi: 10.1016/j.bone.2006.04.003), reports that elderly men benefited from daily supplements of fortified milk.
Osteoporosis is estimated to affect about 75m people in Europe, the USA and Japan. According to the International Osteoporosis Foundation, the total direct cost of osteoporotic fractures is €31.7bn in Europe, and 17.5bn in the US (2002 figure).
Robin Daly and co-workers from Deakin University in Melbourne followed 109 who had completed the earlier study for a further 18 months, during which no more fortified milk was provided.
The benefits on bone mineral density observed in the on the hip bone (femoral neck) and wrist (ultra-distal radius) at the end of the intervention of 1.8 and 1.5 per cent, respectively, were still evident 18 months later.
Furthermore, non-significant increases at the total hip of 0.8 per cent were also sustained.
"The average total dietary calcium intake in the milk supplementation group at follow-up approximated recommended amounts for Australian men older than 50 (1000 mg/d) but did not differ significantly from that in the control subjects (1021 versus 890 mg/d)," stated the researchers for clarification.